Celemics, Inc. (KOSDAQ:331920)

Market Cap	112.60B +350.7%
Revenue (ttm)	5.22B -16.2%
Net Income	-10.17B
EPS	-1,186.46
Shares Out	11.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,896
Open	10,120
Previous Close	9,810
Day's Range	9,550 - 10,120
52-Week Range	2,535 - 19,840
Beta	-0.05
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Celemics

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development se...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2010
• Employees: 46
• Stock Exchange: KOSDAQ
• Ticker Symbol: 331920

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 22, 2026

Data Sources Report a data error